Magrolimab drug page Clinical trials

Trials with Magrolimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
10Countries
155Planned patients

Showing 1–2 of 2

Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
Finished Phase 2 77 patients NCT05330429

The goals of this clinical study are to learn more about the safety, tolerability and effectiveness of magrolimab in combination with bevacizumab and 5-fluorouracil, irinotecan, and leucovorin (FOLFIRI) in previously treated participants w…

United States, Australia, Belgium, Canada and 6 more Jul 2022 – Jun 2024 Interventional
Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer
Finished Phase 1 78 patients NCT02953782

The primary objectives of this study are: (Phase 1b) to investigate the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) for magrolimab in combination with cetuximab; and (Phase 2) to evaluate overall response r…

United States Nov 2016 – Feb 2020 Interventional
Combined with: Cetuximab